OVID
Ovid Therapeutics Inc
2.30$
-1.7%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +15.2% | -8.6% | -10.3% | -13.1% | -10.2% | -11.4% | -5.2% | -17.5% | +136.4% | +49.5% | +2.8% | |
| – | +19.5% | -15.0% | -13.2% | -18.6% | -15.0% | -17.9% | -8.3% | -31.5% | +213.8% | +77.1% | -22.8% | |
| – | -52.9% | +13.8% | -3.5% | -49.4% | +75.1% | -19.6% | +34.4% | -27.5% | -36.2% | +615.2% | -88.0% | |
| – | +21.5% | -14.7% | -14.7% | -18.5% | -15.4% | -19.0% | -10.8% | -33.2% | +172.0% | +123.3% | -24.6% | |
| – | -9.9% | -26.0% | +48.0% | -29.2% | -40.6% | -58.7% | – | – | – | – | – | |
| – | +136.9% | -5.2% | -45.3% | -9.7% | -9.2% | -6.5% | -3.3% | -11.5% | +5.9% | +34.9% | -19.3% | |
| – | +32.4% | -22.4% | +58.6% | -17.6% | -9.5% | -11.5% | -4.1% | -23.8% | +22.0% | +90.0% | -36.6% | |
| – | +1.8% | +1.8% | +1.8% | +1.7% | +1.8% | +1.8% | +1.8% | +1.8% | +1.7% | +1.8% | +1.7% | |
| – | +204.4% | -2.9% | +31.3% | -42.6% | +17.7% | -38.9% | +102.6% | -56.7% | +14.4% | +353.8% | -54.1% | |
| – | -13.3% | -10.8% | +13.6% | -14.2% | -10.6% | -13.1% | -5.9% | -19.9% | +192.3% | +51.7% | +5.9% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.1% | +0.0% | +0.7% | -0.3% | +0.0% | +0.0% | +0.1% | +0.0% | +14.9% | -9.7% | +0.0% |
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.